ANIXA BIOSCIENCES, INC. Equity Method Investment, Realized Gain (Loss) on Disposal
ANIXA BIOSCIENCES, INC. (ANIX) reported Equity Method Investment, Realized Gain (Loss) on Disposal of -$1.14 thousand for the 3-month period ending 2013-01-31, per its 10-Q/A filed 2013-03-25.
Discontinued › Income Statement › Other Income
us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal · last filed 2013-03-25
- ANIXA BIOSCIENCES, INC. equity method investment, realized gain (loss) on disposal for the quarter ending 2013-01-31 was -$1.14K.
- ANIXA BIOSCIENCES, INC. equity method investment, realized gain (loss) on disposal for the quarter ending 2011-10-31 was $0.00.
- ANIXA BIOSCIENCES, INC. equity method investment, realized gain (loss) on disposal for the quarter ending 2011-07-31 was -$60.34K.
- ANIXA BIOSCIENCES, INC. equity method investment, realized gain (loss) on disposal for the quarter ending 2011-04-30 was $26.17K.
- ANIXA BIOSCIENCES, INC. equity method investment, realized gain (loss) on disposal for fiscal 2012 was -$1.00K.
- ANIXA BIOSCIENCES, INC. equity method investment, realized gain (loss) on disposal for fiscal 2011 was -$30.17K, a 729.96% decline from fiscal 2010.
- ANIXA BIOSCIENCES, INC. equity method investment, realized gain (loss) on disposal for fiscal 2010 was $4.79K.
| Period end | Equity Method Investment, Realized Gain (Loss) on Disposal 3 month | Equity Method Investment, Realized Gain (Loss) on Disposal 6 month | Equity Method Investment, Realized Gain (Loss) on Disposal 9 month | Equity Method Investment, Realized Gain (Loss) on Disposal 9 month as first filed | Equity Method Investment, Realized Gain (Loss) on Disposal 12 month | Equity Method Investment, Realized Gain (Loss) on Disposal 12 month as first filed |
|---|---|---|---|---|---|---|
| 2013-01-31 | -$1.14K 10-Q/A · filed 2013-03-25 | |||||
| 2012-10-31 | -$1.00K 10-K · filed 2013-01-29 | |||||
| 2011-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-01-29 | -$60.34K derived: sum of 2 quarters · filed 2013-01-29 | -$34.17K derived: sum of 3 quarters · filed 2013-01-29 | -$30.17K 10-K · filed 2013-01-29 | $30.17K 10-K · filed 2012-01-30 | |
| 2011-07-31 | -$60.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-09-14 | -$34.17K derived: sum of 2 quarters · filed 2012-09-14 | -$30.17K 10-Q · filed 2012-09-14 | $30.17K 10-Q/A · filed 2011-10-14 | -$30.82K derived: sum of 4 quarters · filed 2012-09-14 | |
| 2011-04-30 | $26.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-06-14 | $30.17K 10-Q · filed 2012-06-14 | $29.51K derived: sum of 3 quarters · filed 2012-06-14 | |||
| 2011-01-31 | $4.00K 10-Q · filed 2012-03-16 | $3.35K derived: sum of 2 quarters · filed 2012-03-16 | ||||
| 2010-10-31 | -$655.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-01-30 | $4.79K 10-K · filed 2012-01-30 | ||||
| 2010-07-31 | $5.44K 10-Q/A · filed 2011-10-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |